Drug resistance poses an escalating global challenge in the battle against infections.The effectiveness of conventional antibiotics and other anti-infective drugs is waning as microbes develop heightened resistance to...Drug resistance poses an escalating global challenge in the battle against infections.The effectiveness of conventional antibiotics and other anti-infective drugs is waning as microbes develop heightened resistance to existing treatments.Antimicrobial resistance poses a formidable challenge to global health and development,ranking among the top 10 public health threats to humanity as declared by the World Health Organization.Projections indicate that if left unaddressed,antimicrobial resistance could inflict an annual economic burden on the global GDP ranging from$1trillion to$3.4 trillion by 2030.Consequently,the management of common infections becomes increasingly arduous,while the likelihood of disease transmission,severe illness,and mortality escalates.展开更多
Acta Pharmaceutica Sinica B is pleased to introduce a collection on The Development of Antiviral Drug Discovery,featuring articles published in the journal between January 2020 and January 2025.The discovery of antivi...Acta Pharmaceutica Sinica B is pleased to introduce a collection on The Development of Antiviral Drug Discovery,featuring articles published in the journal between January 2020 and January 2025.The discovery of antiviral drugs is a complex and significant process that requires an in-depth understanding of the viral life cycle,as well as the identification and validation of potential drug targets.Historically,the development of antiviral drugs began in the 1950s.展开更多
文摘Drug resistance poses an escalating global challenge in the battle against infections.The effectiveness of conventional antibiotics and other anti-infective drugs is waning as microbes develop heightened resistance to existing treatments.Antimicrobial resistance poses a formidable challenge to global health and development,ranking among the top 10 public health threats to humanity as declared by the World Health Organization.Projections indicate that if left unaddressed,antimicrobial resistance could inflict an annual economic burden on the global GDP ranging from$1trillion to$3.4 trillion by 2030.Consequently,the management of common infections becomes increasingly arduous,while the likelihood of disease transmission,severe illness,and mortality escalates.
文摘Acta Pharmaceutica Sinica B is pleased to introduce a collection on The Development of Antiviral Drug Discovery,featuring articles published in the journal between January 2020 and January 2025.The discovery of antiviral drugs is a complex and significant process that requires an in-depth understanding of the viral life cycle,as well as the identification and validation of potential drug targets.Historically,the development of antiviral drugs began in the 1950s.
